Vermont Disclosure

Guide to Vermont's pharmaceutical marketer price disclosure law

  1. Home
  2. Products & Resources
  3. Vermont Disclosure

This information is intended for U.S. residents.

33 V.S.A. § 2005a.

Product Name Short Form Long Form Date updated
Aubagio® (teriflunomide) Aubagio Short Form Aubagio Long Form July 23, 2018
Cerdelga (eliglustat) Cerdelga Short Form Cerdelga Long Form July 23, 2018
Hectorol (doxercalciferol) Hectorol Short Form Hectorol Long Form April 23, 2018
Multaq (dronedarone) Multaq Short Form Multaq Long Form July 23, 2018
Renagel (sevelamer hydrochloride) / Renvela (sevelamer carbonate) Renagel / Renvela Short Form Renagel / Renvela Long Form July 23, 2018
Caprelsa (vandetanib) Caprelsa Short Form Caprelsa Long Form July 23, 2018

Guide to Vermont's Pharmaceutical Marketer Price Disclosure Law, 33 V.S.A. § 2005a. Published by the Vermont Office of the Attorney General.

Please See Full Prescribing Information, including Boxed Warning, for Aubagio, Caprelsa and Multaq.

Vermont Disclosure 2


Get more information about the Sanofi group products.